https://www.selleckchem.com/pr....oducts/corticosteron
05). Further Non-parametric test analysis indicated that more CTCs counts were detected in late N and clinical stages patients ( 0.001). The Kaplan-Meier survival analysis indicated that CTCs-positive were correlated with shorter progression-free survival (PFS) ( 0.001) and overall survival (OS) ( 0.001). Further, the CTCs-positive was an independent prognostic factor for PFS and OS according to the Cox multivariate regression analysis ( 0.05). More CTCs were associated with N stage, clinical stage, poor prognosis
Like
Comment
Share
